![](https://privsource-prod.s3.amazonaws.com/8vgf764fwq8obvtn8ckfy01va6u3?response-content-disposition=inline%3B%20filename%3D%22lauxera-capital-partners.png%22%3B%20filename%2A%3DUTF-8%27%27lauxera-capital-partners.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6NYHEBQEVFIPN3SJ%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T103743Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=fac253e16f6c796b43fc4c6269a28cf5e140b94b76cccbf7b3ff20998261709b)
Lauxera Capital Partners and Accelmed Partners Invests in Veranex
05.19.2022
Veranex serves the medical technology industry by providing design, engineering, regulatory, preclinical research, clinical development, commercial strategy, and market access services on an integrated basis. As a result, Veranex helps companies accelerate their speed to market while mitigating the cost and risk of MedTech product development. Since the company's formation in 2021, Veranex has completed six acquisitions to build its position as the leading global product development services provider dedicated to the medical device and biotech space.
Lauxera Capital Partners
Accelmed Partners
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →